Change's Data Can't Be Used Anti-Competitively, Judge Told

By Bryan Koenig ( August 12, 2022, 7:22 PM EDT) -- An expert witness for UnitedHealth Group and Change Healthcare testified Friday there's no real risk the proposed $13. 8 billion deal to buy Change would give a UHG subsidiary a leg up on rival insurers, assailing the U. S. Department of Justice for making overblown predictions about how Change's data could be used to hurt competitors. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login